{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To rapidly reduce inflammation in the optic nerve To prevent further visual loss if cause is Giant Cell Arteritis or NMO\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection required due to high-dose steroid administration\n\n*   **Treatment:** Tocilizumab\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmed diagnosis of Giant Cell Arteritis or NMOSD before initiation\n\n*   **Treatment:** Plasma Exchange (PLEX)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Reserved for steroid-refractory cases of severe demyelinating optic neuritis\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To rapidly reduce inflammation in the optic nerve\", \"To prevent further visual loss if cause is Giant Cell Arteritis or NMO\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection required due to high-dose steroid administration\"]}, {\"treatment\": \"Tocilizumab\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmed diagnosis of Giant Cell Arteritis or NMOSD before initiation\"]}, {\"treatment\": \"Plasma Exchange (PLEX)\", \"timing\": \"Delay\", \"reasons\": [\"Reserved for steroid-refractory cases of severe demyelinating optic neuritis\"]}]"
}